Exosens (EPA:EXENS)
France
· Delayed Price · Currency is EUR 33.80
-0.20 (-0.59%)
May 13, 2025, 5:35 PM CET
Exosens Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 394.08 | 291.82 | 200.75 | 166.17 | 149.86 |
| Revenue Growth (YoY) | 35.04% | 45.36% | 20.81% | 10.88% | - |
| Cost of Revenue | 164.74 | 126.82 | 84.46 | 64.57 | 56.97 |
| Gross Profit | 229.34 | 165 | 116.29 | 101.6 | 92.89 |
| Selling, General & Admin | 114.54 | 84.51 | 64.63 | 57.74 | 53.23 |
| Other Operating Expenses | -0.2 | -2.55 | 21.58 | 14.38 | 9.61 |
| Operating Expenses | 152.53 | 112.36 | 86.2 | 72.12 | 62.85 |
| Operating Income | 76.81 | 52.64 | 30.09 | 29.48 | 30.05 |
| Interest Expense | -35.68 | -26.91 | -15.15 | -37.6 | -41.88 |
| Earnings From Equity Investments | - | - | - | - | 0.04 |
| Currency Exchange Gain (Loss) | 2.15 | -2.68 | 1.57 | 4.38 | -3.66 |
| Other Non Operating Income (Expenses) | 2.32 | 1.54 | 2.93 | -2.66 | 2.22 |
| EBT Excluding Unusual Items | 45.61 | 24.6 | 19.43 | -6.4 | -13.24 |
| Merger & Restructuring Charges | -3.8 | -4.36 | -2.32 | - | - |
| Impairment of Goodwill | - | - | - | -143.87 | - |
| Pretax Income | 41.81 | 20.24 | 17.11 | -150.26 | -13.24 |
| Income Tax Expense | 11.13 | 1.83 | 5.89 | -1.3 | 2.59 |
| Net Income | 30.68 | 18.41 | 11.21 | -148.97 | -15.83 |
| Preferred Dividends & Other Adjustments | 5.15 | 11.05 | 10.41 | - | - |
| Net Income to Common | 25.53 | 7.36 | 0.8 | -148.97 | -15.83 |
| Net Income Growth | 66.68% | 64.17% | - | - | - |
| Shares Outstanding (Basic) | 42 | 30 | 76 | 76 | - |
| Shares Outstanding (Diluted) | 42 | 30 | 76 | 76 | - |
| Shares Change (YoY) | 37.23% | -60.00% | - | - | - |
| EPS (Basic) | 0.61 | 0.24 | 0.01 | -1.96 | - |
| EPS (Diluted) | 0.61 | 0.24 | 0.01 | -1.96 | - |
| EPS Growth | 154.17% | 2300.00% | - | - | - |
| Free Cash Flow | 55 | 19.53 | 25.69 | 23.07 | 30.35 |
| Free Cash Flow Per Share | 1.32 | 0.64 | 0.34 | 0.30 | - |
| Dividend Per Share | 0.100 | - | - | - | - |
| Gross Margin | 58.20% | 56.54% | 57.93% | 61.14% | 61.99% |
| Operating Margin | 19.49% | 18.04% | 14.99% | 17.74% | 20.05% |
| Profit Margin | 6.48% | 2.52% | 0.40% | -89.65% | -10.56% |
| Free Cash Flow Margin | 13.96% | 6.69% | 12.80% | 13.88% | 20.25% |
| EBITDA | 94.4 | 71.94 | 43.56 | 34.99 | 34.87 |
| EBITDA Margin | 23.96% | 24.65% | 21.70% | 21.05% | 23.27% |
| D&A For EBITDA | 17.59 | 19.29 | 13.47 | 5.5 | 4.83 |
| EBIT | 76.81 | 52.64 | 30.09 | 29.48 | 30.05 |
| EBIT Margin | 19.49% | 18.04% | 14.99% | 17.74% | 20.05% |
| Effective Tax Rate | 26.62% | 9.06% | 34.45% | - | - |
| Advertising Expenses | 2.02 | 1.65 | 1.47 | 0.76 | 0.31 |
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.